Data / Drug companies / Discount Drug Mart
Discount Drug Mart: 182 products in the FDA NDC directory, labeler code 53943
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Discount Drug Mart (labeler code 53943) lists 182 products in the FDA National Drug Code Directory, covering 85 finished drugs by generic name. By type: 182 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 1, 2026.
The request: Watch Discount Drug Mart (FDA labeler code 53943): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 53943
- Products in commercial distribution
- 182
- Packages
- 231
- Finished drugs by generic name
- 85
- Prescription products
- 0
- Over the counter products
- 182
- Flagged as original packager
- 161 of 161 products that carry the flag
- Started marketing in the last 12 months
- 3
- Products with a marketing end date set
- 2
- Earliest marketing start
- January 1, 1979
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 141 | 77.5% |
| Generic drugs (ANDA) | 35 | 19.2% |
| New drug applications (NDA) | 3 | 1.6% |
| Other unapproved drugs | 2 | 1.1% |
| Unapproved homeopathic products | 1 | 0.5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 182 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 34 | 18.7% |
| Tablet, coated | 26 | 14.3% |
| Tablet, chewable | 20 | 11% |
| Tablet | 17 | 9.3% |
| Capsule, liquid filled | 10 | 5.5% |
| Tablet, film coated | 8 | 4.4% |
| Solution/ drops | 8 | 4.4% |
| Lozenge | 7 | 3.8% |
| Tablet, delayed release | 6 | 3.3% |
| Spray | 5 | 2.7% |
| Solution | 5 | 2.7% |
| Cream | 4 | 2.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Omeprazole | 53943-038 | Tablet, delayed release | Generic drugs (ANDA) | September 1, 2026 |
| Allergy Relief | 53943-130 | Tablet, film coated | Generic drugs (ANDA) | May 20, 2026 |
| Discount Drug Mart Lubricant Eye Drops | 53943-510 | Solution/ drops | Over the counter monograph drugs | February 25, 2026 |
| Miconazole Nitrate | 53943-976 | Powder | Over the counter monograph drugs | June 3, 2025 |
| DISCOUNT DRUG MART Childrens Allergy Chewable | 53943-033 | Tablet, chewable | Over the counter monograph drugs | May 19, 2025 |
| Esomeprazole Magnesium | 53943-039 | Capsule, delayed release | Generic drugs (ANDA) | March 1, 2025 |
| Supreme Antacid | 53943-614 | Liquid | Over the counter monograph drugs | February 26, 2025 |
| Supreme Antacid Cherry | 53943-613 | Liquid | Over the counter monograph drugs | February 26, 2025 |
| Pink Bismuth Regular Strength | 53943-535 | Liquid | Over the counter monograph drugs | February 26, 2025 |
| Pink Bismuth Original | 53943-529 | Liquid | Over the counter monograph drugs | February 26, 2025 |
| Maximum Strength Pink Bismuth | 53943-528 | Liquid | Over the counter monograph drugs | February 26, 2025 |
| Anti-Diarrheal/Anti-Gas | 53943-263 | Tablet | Generic drugs (ANDA) | February 26, 2025 |
| Fiber laxative | 53943-147 | Tablet | Over the counter monograph drugs | February 26, 2025 |
| Extra Strength Antacid | 53943-129 | Tablet, chewable | Over the counter monograph drugs | February 26, 2025 |
| Pink Bismuth | 53943-122 | Tablet, chewable | Over the counter monograph drugs | February 26, 2025 |
| Extra Strength sugar free Antacid | 53943-181 | Tablet, chewable | Over the counter monograph drugs | February 25, 2025 |
| Ultra Strength Antacid Assorted Fruit | 53943-171 | Tablet, chewable | Over the counter monograph drugs | February 25, 2025 |
| Extra Strength Antacid Tropical Fruit | 53943-127 | Tablet, chewable | Over the counter monograph drugs | February 25, 2025 |
| Extra Strength Antacid | 53943-137 | Tablet, chewable | Over the counter monograph drugs | February 17, 2025 |
| Regular Strength Antacid Regular strength Antacid | 53943-126 | Tablet, chewable | Over the counter monograph drugs | February 17, 2025 |
| Regular Strength Antacid Peppermint | 53943-117 | Tablet, chewable | Over the counter monograph drugs | February 17, 2025 |
| Gas relief | 53943-301 | Tablet, chewable | Over the counter monograph drugs | February 14, 2025 |
| Mucus Relief Max | 53943-234 | Tablet, extended release | Generic drugs (ANDA) | February 14, 2025 |
| Extra Strength Smooth Peppermint Antacid | 53943-180 | Tablet, chewable | Over the counter monograph drugs | February 14, 2025 |
| Extra Strength Smooth Assorted Fruit Antacid | 53943-173 | Tablet, chewable | Over the counter monograph drugs | February 14, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.